Aims and activities
Aims and questions
Aims and activities
The END Fund is a private philanthropic fund, collaborating with governments, NGOs, pharmaceutical and academic partners to end the most common neglected tropical diseases (NTDs).
We help deliver treatment at scale, accelerate innovations that improve the efficiency of drug delivery, provide program oversight to monitor quality and impact, and bring together partners, advocates, and investors. Because we direct resources through local partners, who know the landscape and can go where others cannot or will not, we operate successfully and with measurable impact in some of the world’s most challenging environments. Our focus has always been on large-scale change, and we are committed to investing in and alongside local governments, building in-country technical tools and skills, and incorporating NTDs into national health agendas for local ownership.
How to get involved
We welcome new investors to our philanthropic fund at any level, and are happy to discuss ways in which your investment could be put to best use. We are keen to discuss opportunities to collaborate with others on research and advocacy opportunities, and to leverage our platform to progress our shared goal of ending the world's most prevalent NTDs by 2030. We are also exploring cross-sector collaborations, and willing to lead or join funding consortia in order to progress shared outcomes in education, child health, water, sanitation and hygiene, nutrition, and economic inclusion.
If you would like to get involved, contact Bridie Layden (The END Fund's UK-based Director, Investor Relations).
Who's involved
Who was involved
Who was involved
We work with private philanthropists across the world and partner with national governments and implementing organisations in each country where we operate, predominantly in Africa.
Learning and Resources
We have a catalogue of resources we can share showing the impact of eliminating neglected tropical diseases. For example, economic modelling from the Economist Intelligence Unit found that $5.1 billion in productivity gains between 2021-2040 could result from achieving the WHO’s 2030 targets for eliminating intestinal worms and schistosomiasis as a public health problem in Ethiopia, Kenya, Rwanda, and Zimbabwe.
